MBS8(1V270)

· MonTa Biosciences ApS

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MBS8(1V270), covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours [Phase 1]